Piramal Pharma Limited (PPLPHARMA) — Free Cash Flow Generation Index
Piramal Pharma Limited (PPLPHARMA) has a Free Cash Flow Generation Index of 0.51x as of September 2025. Free cash flow of Rs4.57 Billion represents 1% of operating cash flow (Rs8.90 Billion). Read Piramal Pharma Limited total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Piramal Pharma Limited Free Cash Flow Generation Index (2021–2026)
Historical FCF Generation Index trend for Piramal Pharma Limited across 6 annual periods. Explore PPLPHARMA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Piramal Pharma Limited (2021–2026)
Year-by-year Free Cash Flow Generation Index for Piramal Pharma Limited. For the full company profile including market capitalisation, see market cap of Piramal Pharma Limited.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.36x | Rs5.10 Billion | Rs14.00 Billion | Rs8.90 Billion | ▲ +42.5% |
| 2025 | 0.26x | Rs2.28 Billion | Rs8.92 Billion | Rs6.64 Billion | ▼ -12.3% |
| 2024 | 0.29x | Rs2.92 Billion | Rs10.05 Billion | Rs7.12 Billion | ▲ +129.3% |
| 2023 | -0.99x | Rs-4.81 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -563.7% |
| 2022 | 0.21x | Rs546.90 Million | Rs2.55 Billion | Rs2.01 Billion | ▲ +131.8% |
| 2021 | -0.67x | Rs-233.90 Million | Rs347.20 Million | Rs581.10 Million | — |